These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

334 related articles for article (PubMed ID: 11850790)

  • 21. Structural RNA mimetics: N3'-->P5' phosphoramidate DNA analogs of HIV-1 RRE and TAR RNA form A-type helices that bind specifically to Rev and Tat-related peptides.
    Rigl CT; Lloyd DH; Tsou DS; Gryaznov SM; Wilson WD
    Biochemistry; 1997 Jan; 36(3):650-9. PubMed ID: 9012680
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of a quinoxaline derivative that is a potent telomerase inhibitor leading to cellular senescence of human cancer cells.
    Kim JH; Kim JH; Lee GE; Kim SW; Chung IK
    Biochem J; 2003 Jul; 373(Pt 2):523-9. PubMed ID: 12689331
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibition of telomerase activity of melanoma cells in vitro by antisense oligonucleotides.
    Glukhov AI; Zimnik OV; Gordeev SA; Severin SE
    Biochem Biophys Res Commun; 1998 Jul; 248(2):368-71. PubMed ID: 9675142
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synthesis of oligodeoxyribonucleotide N3'-->P5' phosphoramidates.
    Chen JK; Schultz RG; Lloyd DH; Gryaznov SM
    Nucleic Acids Res; 1995 Jul; 23(14):2661-8. PubMed ID: 7651827
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Telomerase antagonists GRN163 and GRN163L inhibit tumor growth and increase chemosensitivity of human hepatoma.
    Djojosubroto MW; Chin AC; Go N; Schaetzlein S; Manns MP; Gryaznov S; Harley CB; Rudolph KL
    Hepatology; 2005 Nov; 42(5):1127-36. PubMed ID: 16114043
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synthesis and properties of RNA analogs-oligoribonucleotide N3'-->P5' phosphoramidates.
    Matray TJ; Gryaznov SM
    Nucleic Acids Res; 1999 Oct; 27(20):3976-85. PubMed ID: 10497261
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Oligo-2'-fluoro-2'-deoxynucleotide N3'-->P5' phosphoramidates: synthesis and properties.
    Schultz RG; Gryaznov SM
    Nucleic Acids Res; 1996 Aug; 24(15):2966-73. PubMed ID: 8760881
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Oligonucleotide N3'-->P5' phosphoramidates as potential therapeutic agents.
    Gryaznov SM
    Biochim Biophys Acta; 1999 Dec; 1489(1):131-40. PubMed ID: 10807003
    [TBL] [Abstract][Full Text] [Related]  

  • 29. 2-5A antisense therapy directed against human telomerase RNA inhibits telomerase activity and induces apoptosis without telomere impairment in cervical cancer cells.
    Yatabe N; Kyo S; Kondo S; Kanaya T; Wang Z; Maida Y; Takakura M; Nakamura M; Tanaka M; Inoue M
    Cancer Gene Ther; 2002 Jul; 9(7):624-30. PubMed ID: 12082463
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Specific telomere dysfunction induced by GRN163L increases radiation sensitivity in breast cancer cells.
    Gomez-Millan J; Goldblatt EM; Gryaznov SM; Mendonca MS; Herbert BS
    Int J Radiat Oncol Biol Phys; 2007 Mar; 67(3):897-905. PubMed ID: 17175117
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The detection of oligonucleotide N3'-->P5' phosphoramidate/RNA duplexes with capillary gel electrophoresis.
    DeDionisio L; Raible AM; Gryaznov SM
    Electrophoresis; 1998 Jun; 19(8-9):1265-9. PubMed ID: 9694262
    [TBL] [Abstract][Full Text] [Related]  

  • 32. New Oligonucleotide 2'-O-Alkyl N3'→P5' (Thio)-Phosphoramidates as Potent Antisense Agents: Physicochemical Properties and Biological Activity.
    Martínez-Montero S; Rajwanshi VK; Pandey RK; De Costa NTS; Hong J; Beigelman L; Gryaznov SM; Pourshahian S
    Nucleic Acid Ther; 2023 Oct; 33(5):319-328. PubMed ID: 37638793
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Oligonucleotide N3'-->P5' phosphoramidates.
    Gryaznov SM; Lloyd DH; Chen JK; Schultz RG; DeDionisio LA; Ratmeyer L; Wilson WD
    Proc Natl Acad Sci U S A; 1995 Jun; 92(13):5798-802. PubMed ID: 7541136
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Telomerase template antagonist GRN163L disrupts telomere maintenance, tumor growth, and metastasis of breast cancer.
    Hochreiter AE; Xiao H; Goldblatt EM; Gryaznov SM; Miller KD; Badve S; Sledge GW; Herbert BS
    Clin Cancer Res; 2006 May; 12(10):3184-92. PubMed ID: 16707619
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacological intervention strategies for affecting telomerase activity: future prospects to treat cancer and degenerative disease.
    Tárkányi I; Aradi J
    Biochimie; 2008 Jan; 90(1):156-72. PubMed ID: 17945408
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synthesis and properties of ENA oligonucleotides targeted to human telomerase RNA subunit.
    Horie M; Morita K; Kawakami J; Tsutsumi S; Ando O; Koizumi M
    Nucleic Acids Symp Ser (Oxf); 2005; (49):171-2. PubMed ID: 17150688
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Analysis of an oligonucleotide N3'-->P5' phosphoramidate/phosphorothioate chimera with capillary gel electrophoresis.
    DeDionisio LA; Raible AM; Nelson JS
    Electrophoresis; 1998 Nov; 19(16-17):2935-8. PubMed ID: 9870392
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Simultaneous targeting of telomeres and telomerase as a cancer therapeutic approach.
    Mo Y; Gan Y; Song S; Johnston J; Xiao X; Wientjes MG; Au JL
    Cancer Res; 2003 Feb; 63(3):579-85. PubMed ID: 12566299
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of cisplatin on telomerase activity and telomere length in BEL-7404 human hepatoma cells.
    Zhang RG; Zhang RP; Wang XW; Xie H
    Cell Res; 2002 Mar; 12(1):55-62. PubMed ID: 11942411
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibition of human telomerase enhances the effect of chemotherapeutic agents in lung cancer cells.
    Misawa M; Tauchi T; Sashida G; Nakajima A; Abe K; Ohyashiki JH; Ohyashiki K
    Int J Oncol; 2002 Nov; 21(5):1087-92. PubMed ID: 12370759
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.